Nucleobindin protein, which was first identified in human and mouse cell lines, has two isotypes: nucleobindin 1 (NUCB1) and nucleobindin 2 (NUCB2) (Barnikol-Watanabe et al., 1994; Miura et al., 1992). However, NUCB2 only functions physiologically in humans and rodents (Miura et al., 1992). Nesfatin-1, nesfatin-2, and nesfatin-3 are generated through post-translational processing of NUCB2 via the enzyme pro-hormone convertase-1/3 (Gonzalez et al., 2010; Oh-I et al., 2006). A physiological activity has only been demonstrated for nesfatin-1 (Gonzalez et al., 2010). Nesfatin-1 is expressed in various hypothalamic nuclei for appetite control such as the arcuate nucleus (ARC), paraventricular nucleus (PVN), supraoptic nucleus (SO), lateral hypothalamic area (LHA), and zona incerta in rats (Brailoiu et al., 2007; Fort et al., 2008; García-Galiano et al., 2010; Goebel et al., 2009; Kohno et al., 2008). Nesfatin-1 also exists in cerebrospinal fluid and the brain stem, including the locus coeruleus, rostral raphe pallidus, Edinger-Westphal nucleus, and ventrolateral medulla (Goebel et al., 2009; Stengel et al., 2010). Intracerebroventricular infusion of nesfatin-1 decreases food intake and inhibits feeding behavior (Atsuchi et al., 2010; Shimizu et al., 2009), whereas infusion of a nesfatin-1-neutralizing antibody stimulates appetite (Oh-I et al., 2006).